Literature DB >> 7616537

Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis.

J P Evans1, W Burke, R Chen, R L Bennett, R A Schmidt, E P Dellinger, M Kimmey, D Crispin, T A Brentnall, D R Byrd.   

Abstract

We report a large pedigree in which pancreatic cancer is inherited in an autosomal dominant fashion. Diabetes and exocrine insufficiency was observed in all family members who eventually developed pancreatic cancer. The presence of diabetes, often years before the diagnosis of cancer, allowed identification of those people who had inherited the predisposing allele and who were thus at high risk for the development of malignancy. This family shows that genetic factors can have a striking effect on the development of pancreatic malignancy and diabetes mellitus. Moreover, preclinical diagnosis of pancreatic cancer in family members provided a unique opportunity to study early molecular changes that accompany the development of human pancreatic cancer. Finally, the molecular approach applied here to the early diagnosis of pancreatic cancer may prove valuable in this family for identification of subjects at risk.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616537      PMCID: PMC1050425          DOI: 10.1136/jmg.32.5.330

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  17 in total

1.  Purification of DNA from formaldehyde fixed and paraffin embedded human tissue.

Authors:  S E Goelz; S R Hamilton; B Vogelstein
Journal:  Biochem Biophys Res Commun       Date:  1985-07-16       Impact factor: 3.575

2.  Adenocarcinoma of the pancreas in four siblings.

Authors:  R P MacDermott; P Kramer
Journal:  Gastroenterology       Date:  1973-07       Impact factor: 22.682

3.  Pancreatic cancer in father and son.

Authors:  R R Reimer; J F Fraumeni; R F Ozols; R Bender
Journal:  Lancet       Date:  1977-04-23       Impact factor: 79.321

4.  Pancreatic carcinoma in brothers.

Authors:  N M Dat; S J Sontag
Journal:  Ann Intern Med       Date:  1982-08       Impact factor: 25.391

5.  Familial carcinoma of the pancreas.

Authors:  J M Friedman; P J Fialkow
Journal:  Clin Genet       Date:  1976-05       Impact factor: 4.438

6.  Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.

Authors:  M Tada; M Omata; S Kawai; H Saisho; M Ohto; R K Saiki; J J Sninsky
Journal:  Cancer Res       Date:  1993-06-01       Impact factor: 12.701

7.  Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease.

Authors:  J Cuzick; A G Babiker
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396

8.  A familial aggregation of pancreatic cancer. An in vitro study.

Authors:  B S Danes; H T Lynch
Journal:  JAMA       Date:  1982-05-28       Impact factor: 56.272

9.  Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature.

Authors:  D Ehrenthal; L Haeger; T Griffin; C Compton
Journal:  Cancer       Date:  1987-05-01       Impact factor: 6.860

10.  Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes.

Authors:  C Almoguera; D Shibata; K Forrester; J Martin; N Arnheim; M Perucho
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

View more
  13 in total

1.  Inherited predisposition to pancreatic cancer.

Authors:  E Efthimiou; T Crnogorac-Jurcevic; N R Lemoine; T A Brentnall
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

2.  Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma.

Authors:  S T Dergham; M C Dugan; P Arlauskas; W Du; V K Vaitkevicius; J D Crissman; F H Sarkar
Journal:  Int J Pancreatol       Date:  1997-06

Review 3.  Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis.

Authors:  Jennifer Permuth-Wey; Kathleen M Egan
Journal:  Fam Cancer       Date:  2008-09-02       Impact factor: 2.375

4.  Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.

Authors:  Renata Talar-Wojnarowska; Anita Gasiorowska; Beata Smolarz; Hanna Romanowicz-Makowska; Janusz Strzelczyk; Adam Janiak; Andrzej Kulig; Ewa Malecka-Panas
Journal:  Int J Gastrointest Cancer       Date:  2005

Review 5.  Pancreatic adenocarcinoma: epidemiology and genetics.

Authors:  T Y Flanders; W D Foulkes
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

6.  The prevention and genetics of pancreatic cancer: a programmatic approach.

Authors:  Aimee L Lucas; Michelle M Chang; Marla D Lipsyc; Harold Frucht
Journal:  Methods Mol Biol       Date:  2013

Review 7.  Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.

Authors:  Andrew E Becker; Yasmin G Hernandez; Harold Frucht; Aimee L Lucas
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

8.  Advances in the Genetic Screening, Work-up, and Treatment of Pancreatic Cancer.

Authors:  Harold Frucht; Peter D. Stevens; David R. Fogelman; Elizabeth C. Verna; Johnson Chen; John A. Chabot; Robert L. Fine
Journal:  Curr Treat Options Gastroenterol       Date:  2004-10

9.  Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.

Authors:  Kay L Pogue-Geile; Ru Chen; Mary P Bronner; Tatjana Crnogorac-Jurcevic; Kara White Moyes; Sally Dowen; Carol A Otey; David A Crispin; Ryan D George; David C Whitcomb; Teresa A Brentnall
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

10.  Molecular analysis of precursor lesions in familial pancreatic cancer.

Authors:  Tatjana Crnogorac-Jurcevic; Claude Chelala; Sayka Barry; Tomohiko Harada; Vipul Bhakta; Sam Lattimore; Stipo Jurcevic; Mary Bronner; Nicholas R Lemoine; Teresa A Brentnall
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.